Email updates

Keep up to date with the latest news and content from Chemistry Central Journal and Chemistry Central.

Open Access Highly Accessed Research article

Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv)

Deepak Singla13, Rupinder Tewari3, Ashwani Kumar2, Gajendra PS Raghava1* and Open Source Drug Discovery Consortium4

Author Affiliations

1 Bioinformatics Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India

2 Infectious Diseases and Immunology, CSIR-Institute of Microbial Technology, Chandigarh, India

3 Centre For Microbial Biotechnology, Panjab University, Chandigarh, India

4 CSIR Open Source Drug Discovery Unit, Anusandhan Bhavan, 2 Rafi Marg, Delhi, 110001, India

For all author emails, please log on.

Chemistry Central Journal 2013, 7:49  doi:10.1186/1752-153X-7-49

Published: 8 March 2013

Abstract

Background

Mycobacterium tuberculosis (M.tb) is the causative agent of tuberculosis, killing ~1.7 million people annually. The remarkable capacity of this pathogen to escape the host immune system for decades and then to cause active tuberculosis disease, makes M.tb a successful pathogen. Currently available anti-mycobacterial therapy has poor compliance due to requirement of prolonged treatment resulting in accelerated emergence of drug resistant strains. Hence, there is an urgent need to identify new chemical entities with novel mechanism of action and potent activity against the drug resistant strains.

Results

This study describes novel computational models developed for predicting inhibitors against both replicative and non-replicative phase of drug-tolerant M.tb under carbon starvation stage. These models were trained on highly diverse dataset of 2135 compounds using four classes of binary fingerprint namely PubChem, MACCS, EState, SubStructure. We achieved the best performance Matthews correlation coefficient (MCC) of 0.45 using the model based on MACCS fingerprints for replicative phase inhibitor dataset. In case of non-replicative phase, Hybrid model based on PubChem, MACCS, EState, SubStructure fingerprints performed better with maximum MCC value of 0.28. In this study, we have shown that molecular weight, polar surface area and rotatable bond count of inhibitors (replicating and non-replicating phase) are significantly different from non-inhibitors. The fragment analysis suggests that substructures like hetero_N_nonbasic, heterocyclic, carboxylic_ester, and hetero_N_basic_no_H are predominant in replicating phase inhibitors while hetero_O, ketone, secondary_mixed_amine are preferred in the non-replicative phase inhibitors. It was observed that nitro, alkyne, and enamine are important for the molecules inhibiting bacilli residing in both the phases. In this study, we introduced a new algorithm based on Matthews correlation coefficient called MCCA for feature selection and found that this algorithm is better or comparable to frequency based approach.

Conclusion

In this study, we have developed computational models to predict phase specific inhibitors against drug resistant strains of M.tb grown under carbon starvation. Based on simple molecular properties, we have derived some rules, which would be useful in robust identification of tuberculosis inhibitors. Based on these observations, we have developed a webserver for predicting inhibitors against drug tolerant M.tb H37Rv available at http://crdd.osdd.net/oscadd/mdri/ webcite.

Graphical abstract